Sign In

Login

Password

Forgot Password ? Sign Up

Ganciclovir (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ganciclovir" in Italian language version.

refsWebsite
Global rank Italian rank
18nih.gov
4th place
9th place
4oadoi.org
799th place
22nd place
4doi.org
2nd place
7th place
1fda.gov
447th place
644th place

doi.org

dx.doi.org

fda.gov

nih.gov

ncbi.nlm.nih.gov

  • CV. Fletcher, HH. Balfour, Evaluation of ganciclovir for cytomegalovirus disease., in DICP, vol. 23, n. 1, Gen 1989, pp. 5-12, PMID 2541566.
  • T. Matthews, R. Boehme, Antiviral activity and mechanism of action of ganciclovir., in Rev Infect Dis, 10 Suppl 3, pp. S490-4, PMID 2847285.
  • P. Reusser, Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options., in J Hosp Infect, vol. 33, n. 4, Ago 1996, pp. 235-48, PMID 8864937.
  • S. Noble, D. Faulds, Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients., in Drugs, vol. 56, n. 1, Lug 1998, pp. 115-46, PMID 9664203.
  • AC. Tsinontides, TP. Bechtel, Cytomegalovirus prophylaxis and treatment following bone marrow transplantation., in Ann Pharmacother, vol. 30, n. 11, Nov 1996, pp. 1277-90, PMID 8913411.
  • JK. McGavin, KL. Goa, Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients., in Drugs, vol. 61, n. 8, 2001, pp. 1153-83, PMID 11465876.
  • EM. Hodson, M. Ladhani; AC. Webster; GF. Strippoli; JC. Craig, Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients., in Cochrane Database Syst Rev, vol. 2, 2013, pp. CD003774, DOI:10.1002/14651858.CD003774.pub4, PMID 23450543.
  • JD. Croxtall, Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers)., in Drugs, vol. 71, n. 5, Mar 2011, pp. 603-10, DOI:10.2165/11207240-000000000-00000, PMID 21443283.
  • HE. Kaufman, WH. Haw, Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis., in Curr Eye Res, vol. 37, n. 7, Lug 2012, pp. 654-60, DOI:10.3109/02713683.2012.692846, PMID 22607463.
  • B. Salzberger, RA. Bowden; RC. Hackman; C. Davis; M. Boeckh, Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome., in Blood, vol. 90, n. 6, Set 1997, pp. 2502-8, PMID 9310503.
  • ML. Dubreuil-Lemaire, A. Gori; D. Vittecoq; G. Panelatti; F. Tharaux; R. Palisses; S. Gharakhanian; W. Rozenbaum, Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo-controlled trial in AIDS patients., in Eur J Haematol, vol. 65, n. 5, Nov 2000, pp. 337-43, PMID 11092465.
  • A. Tomonari, T. Iseki; S. Takahashi; J. Ooi; T. Yamada; K. Takasugi; F. Nagamura; K. Uchimaru; A. Tojo; S. Asano, Ganciclovir-related neutropenia after preemptive therapy for cytomegalovirus infection: comparison between cord blood and bone marrow transplantation., in Ann Hematol, vol. 83, n. 9, Set 2004, pp. 573-7, DOI:10.1007/s00277-004-0887-2, PMID 15221283.
  • TL. Barton, MK. Roush; LL. Dever, Seizures associated with ganciclovir therapy., in Pharmacotherapy, vol. 12, n. 5, 1992, pp. 413-5, PMID 1331995.
  • R. Sannerstedt, P. Lundborg; BR. Danielsson; I. Kihlström; G. Alván; B. Prame; E. Ridley, Drugs during pregnancy: an issue of risk classification and information to prescribers., in Drug Saf, vol. 14, n. 2, Feb 1996, pp. 69-77, PMID 8852521.
  • PJ. Cimoch, J. Lavelle; R. Pollard; KG. Griffy; R. Wong; TL. Tarnowski; S. Casserella; D. Jung, Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects., in J Acquir Immune Defic Syndr Hum Retrovirol, vol. 17, n. 3, Mar 1998, pp. 227-34, PMID 9495222.
  • MA. Jacobson, P. de Miranda; SM. Gordon; MR. Blum; P. Volberding; J. Mills, Prolonged pancytopenia due to combined ganciclovir and zidovudine therapy., in J Infect Dis, vol. 158, n. 2, Ago 1988, pp. 489-90, PMID 3261316.
  • H. Hochster, D. Dieterich; S. Bozzette; RC. Reichman; JD. Connor; L. Liebes; RL. Sonke; SA. Spector; F. Valentine; C. Pettinelli, Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study., in Ann Intern Med, vol. 113, n. 2, Lug 1990, pp. 111-7, PMID 2163228.
  • D. Jung, K. Griffy; A. Dorr; R. Raschke; TL. Tarnowski; J. Hulse; RE. Kates, Effect of high-dose oral ganciclovir on didanosine disposition in human immunodeficiency virus (HIV)-positive patients., in J Clin Pharmacol, vol. 38, n. 11, Nov 1998, pp. 1057-62, PMID 9824788.

oadoi.org